No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs574454833 |
chr2:73852526-73852527 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs541868535 |
chr2:73852532-73852533 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs563324774 |
chr2:73852535-73852536 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs531096236 |
chr2:73852536-73852537 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs552875403 |
chr2:73852549-73852550 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs564474236 |
chr2:73852550-73852551 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs528670108 |
chr2:73852557-73852558 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs546654021 |
chr2:73852565-73852566 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs568237378 |
chr2:73852576-73852577 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs535579364 |
chr2:73852579-73852580 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs185902778 |
chr2:73852647-73852648 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs386647345 |
chr2:73852648-73852649 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs536941487 |
chr2:73852649-73852650 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs115425992 |
chr2:73852650-73852651 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs138283747 |
chr2:73852710-73852711 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs369733155 |
chr2:73852713-73852714 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs571973720 |
chr2:73852746-73852747 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs192349240 |
chr2:73852764-73852765 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs574562333 |
chr2:73852765-73852766 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs541943479 |
chr2:73852777-73852778 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs563129101 |
chr2:73852836-73852837 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs575198202 |
chr2:73852840-73852841 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs11281455 |
chr2:73852931-73852932 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs567976042 |
chr2:73852935-73852936 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs200675522 |
chr2:73852938-73852939 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs60049316 |
chr2:73852945-73852946 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs577165285 |
chr2:73852950-73852951 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs558056852 |
chr2:73852992-73852993 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs56963877 |
chr2:73853001-73853002 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs183718515 |
chr2:73853010-73853011 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs553563754 |
chr2:73853016-73853017 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs186099687 |
chr2:73853029-73853030 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs546765887 |
chr2:73853041-73853042 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs11683970 |
chr2:73853057-73853058 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs529335206 |
chr2:73853160-73853161 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs77768313 |
chr2:73853169-73853170 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs551099551 |
chr2:73853187-73853188 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs569112004 |
chr2:73853254-73853255 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs148802028 |
chr2:73853259-73853260 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs190469453 |
chr2:73853308-73853309 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs570785683 |
chr2:73853309-73853310 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs534944565 |
chr2:73853311-73853312 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs553189570 |
chr2:73853355-73853356 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs376081611 |
chr2:73853380-73853381 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs535197341 |
chr2:73853445-73853446 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs557026837 |
chr2:73853463-73853464 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs575095387 |
chr2:73853477-73853478 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs4241256 |
chr2:73853509-73853510 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs557534942 |
chr2:73853513-73853514 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs573181998 |
chr2:73853565-73853566 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|